Titre:
  • Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Auteur:Fumagalli, Debora; Blanchet-Cohen, Alexis; Brown, David; Desmedt, Christine; Gacquer, David; Michiels, Stefan; Rothé, Françoise; Majjaj, Samira; Salgado, Roberto; Larsimont, Denis; Ignatiadis, Michail; Maetens, Marion M.; Piccart-Gebhart, Martine; Detours, Vincent; Sotiriou, Christos; Haibe-Kains, Benjamin
Informations sur la publication:BMC genomics, 15, 1, page (1008)
Statut de publication:Publié, 2014-11-21
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Mots-clés:Affymetrix
Breast cancer
Estrogen receptor
Gene expression signatures
HER2 receptor
Illumina
Immunohistochemistry
Microarray
Progesterone receptor
RNA-Seq
MeSH keywords:Base Sequence
Estrogen Receptor alpha -- biosynthesis
Female
Gene Expression Regulation, Neoplastic
High-Throughput Nucleotide Sequencing
Humans
Neoplasm Proteins -- biosynthesis
Oligonucleotide Array Sequence Analysis
Prognosis
Receptor, ErbB-2 -- biosynthesis
Receptors, Progesterone -- biosynthesis
Transcriptome -- genetics
Triple Negative Breast Neoplasms -- genetics -- pathology
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1471-2164
info:doi/10.1186/1471-2164-15-1008
info:pii/1471-2164-15-1008
info:scp/84924333189
info:pmid/25412710